| Trial ID: | L6846 |
| Source ID: | NCT00276393
|
| Associated Drug: |
Basal Insulin
|
| Title: |
Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Basal insulin
|
| Outcome Measures: |
Primary: HbA1c|Hypoglycemic events|Nocturnal hypoglycemia|Mean glucose|Mean fasting glucose | Secondary: Days of titration of basal insulin|Fear of hypoglycemia|Continuos glucose monitoring
|
| Sponsor/Collaborators: |
Sponsor: Mayo Clinic
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
22
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-07
|
| Completion Date: |
2003-12
|
| Results First Posted: |
|
| Last Update Posted: |
2011-05-23
|
| Locations: |
Mayo Clinic, Rochester, Minnesota, 55905, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00276393
|
